Elacestrant Improves Progression-Free Survival After Endocrine Therapy for Estrogen Receptor-Positive Metastatic Breast Cancer

被引：4
|
作者：
Jacobson, Anne
机构：
来源：
ONCOLOGIST | 2022年 / 27卷
关键词：
D O I：
10.1093/oncolo/oyac015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [31] Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer
    Jones, Veronica
    Yin, Hongwei Holly
    Yuan, Yate-Ching
    Wang, Yongzhe
    Li, Sierra Min
    Aljaber, Dana
    Sanchez, Angelica
    Quinones, Christine
    Schmolze, Dan
    Yuan, Yuan
    Mortimer, Joanne
    Yee, Lisa
    Kruper, Laura
    Jovanovic-Talisman, Tijana
    Tomsic, Jerneja
    Sanchez, Nancy
    Chavez, Tanya
    O'Regan, Ruth M.
    Khan, Qamar J.
    Davis, Melissa
    Kalinsky, Kevin
    Meisel, Jane
    Kittles, Rick
    Rodriguez-Rodriguez, Lorna
    Seewaldt, Victoria
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [32] Abbreviated endocrine therapy duration for low estrogen receptor-positive breast cancer: The counter to extended endocrine therapy
    Poterala, Johanna E.
    Wisinski, Kari B.
    CANCER, 2022, 128 (09) : 1724 - 1726
  • [33] A PROMISING ALTERNATIVE: NEOADJUVANT ENDOCRINE THERAPY IN ESTROGEN AND PROGESTERONE RECEPTOR-POSITIVE BREAST CANCER
    Malik, H.
    Pham, C.
    Garcia, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 556 - 557
  • [34] Endocrine therapy treatment radiosensitizes estrogen receptor-positive breast cancers
    Michmerhuizen, Anna R.
    Lerner, Lynn
    Pesch, Andrea M.
    Ward, Connor
    Schwartz, Rachel
    Wilder-Romans, Kari
    Liu, Meilan
    Wharram, Bryan
    Harold, Alexis
    Azaria, Ruth
    Garcia, Nicole Zambrana
    Hayes, Daniel F.
    Rae, James M.
    Pierce, Lori J.
    Speers, Corey W.
    CANCER RESEARCH, 2022, 82 (04)
  • [35] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [36] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [37] Progression free survival with endocrine therapy, before or after chemotherapy, in patients with hormone receptor-positive/HER2-negative metastatic breast cancer in a large multicenter national observational study
    Corbaux, P.
    Lardy-Cleaud, A.
    Alexandre, M.
    Fontanilles, M.
    Levy, C.
    Viansone, A. A.
    Mailliez, A.
    Debled, M.
    Goncalves, A.
    Le Du, F.
    Lerebours, F.
    Ferrero, J-M.
    Eymard, J-C.
    Mouret-Reynier, M-A.
    Petit, T.
    Frenel, J-S.
    Pons-Tostivint, E.
    Courtinard, C.
    Chaix, M.
    Bachelot, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S353 - S353
  • [38] Fulvestrant plus capivasertib versus fulvestrant plus placebo after relapse or progression on an aromatase inhibitor in metastatic, estrogen receptor-positive breast cancer (FAKTION): Overall survival and updated progression-free survival data with enhanced biomarker analysis.
    Jones, Robert Hugh
    Casbard, Angela Claire
    Carucci, Margherita
    Ingarfield-Herbert, Kate
    Butler, Rachel
    Morgan, Sian
    Meissner, Magdalena
    Bale, Catherine Jane
    Bezecny, Pavel
    Moon, Sarah
    Twelves, Chris
    Venkitaraman, Ramachandran
    Waters, Simon
    De Bruin, Elza
    Schiavon, Gaia
    Foxley, Andrew
    Howell, Sacha Jon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Beyond the median: Estimating survival times for patients starting endocrine therapy for estrogen receptor-positive, metastatic breast cancer from recent randomized trials
    Parsonson, Andrew O.
    Sarkar, Sunit
    Brown, Lauren
    Low, Gary K. K.
    Kiely, Belinda E.
    Vasista, Anuradha
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (06) : 714 - 722
  • [40] Identify high risk estrogen receptor-positive breast cancer patients for extended endocrine therapy
    Li, JunJie
    Jiang, Yizhou
    Liu, Yirong
    Shao, Zhimin
    BREAST, 2017, 31 : 173 - 180
12345